Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
Study carried out between the 10 February and the 01 March 2016.
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2016
Report date:
2016

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 442B (Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA): BrdU-ELISA

Test material

Constituent 1
Reference substance name:
Calendula officinalis, ext.
EC Number:
283-949-5
EC Name:
Calendula officinalis, ext.
Cas Number:
84776-23-8
Molecular formula:
UVCB substance, not relevant.
IUPAC Name:
Calendula officinalis, ext.
Test material form:
liquid
Specific details on test material used for the study:
Teinture mère de Calendula officinalis – code C19F. Batch No.: M4080014

In vivo test system

Study design: in vivo (LLNA)

Vehicle:
dimethylformamide
Concentration:
Groups of four mice were treated with the test item at 100% and diluted at 50% and 25% in the vehicle Dimethyl formamide (DMF).
No. of animals per dose:
four mice per dose
Details on study design:
The mice were treated by daily application of 25 µL of the appropriate concentration of the test item to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test item formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette.
Positive control substance(s):
other: vehicle

Results and discussion

In vivo (LLNA)

Results
Key result
Parameter:
SI
Value:
ca. 0.75
Variability:
The Stimulation Index (SI) calculated by individual approach was 0.83, 0.80 and 0.75 for the treated groups at 25%, 50% and 100%, respectively.
Test group / Remarks:
The EC1.6 cannot be determined in this study.
Remarks on result:
other:
Remarks:
No Stimulation index of more than 1.6 was recorded with the three tested concentrations.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The results obtained, in these experimental conditions, enable to conclude that the test item Tincture mother of Calendula officinalis (Teinture mère de Calendula officinalis) – code C19F does not have to be classified in category 1, in accordance with the Regulation EC No. 1272/2008 on classification, labelling and packaging of substances and mixtures.